The generic release date of Feraheme could potentially be after June 30, 2023. This is based on the expiry date of the last patent, US6599498, named as Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohydrate derivatives, which is expected to expire on June 30, 2023.
Feraheme is used for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron. Its active ingredient, ferumoxytol, replenishes iron stores in your body and helps improve symptoms of anemia.
Feraheme holds a total of 1 drug patent, which has already expired. The patent, US6599498, was titled as 'Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohydrate derivatives', and its expiry date was June 30, 2023. Hence, it's possible that the Feraheme generic could be available upon further approvals after June 30, 2023. Below are the details of the patent: